Final answer:
The type of asthma is mild persistent with symptoms occurring twice a week, and normal pulmonary function tests indicate the presence of inflammation without permanent airway changes. Treatment includes low-dose inhaled corticosteroids and short-acting beta-agonists as needed for acute symptoms. Personalized treatment and trigger avoidance are essential.
Step-by-step explanation:
The type of asthma being described with symptoms occurring twice a week and normal pulmonary function tests (PFTs) suggests mild persistent asthma. Treatment for mild persistent asthma generally includes low-dose inhaled corticosteroids or other anti-inflammatory medication to control inflammation and prevent symptoms, as well as a short-acting beta-agonist as needed for acute symptoms.
It's important to recognize asthma's hallmarks: airway obstruction, inflammation, and increased mucous production. During an asthma attack, patients may experience coughing, wheezing, shortness of breath, and chest tightness. Severe attacks could require short-term, fast-acting medication administered via an inhaler or, for some patients, a nebulizer to deliver the medication more efficiently.
Regular monitoring and avoidance of known triggers, while adhering to a prescribed treatment plan, can help manage asthma symptoms and enhance quality of life. Always consult a healthcare provider for a proper diagnosis and personalized treatment plan.